obesity drug news today glp-1 september 22 2025 Periodic Graphics: The science of weight-loss drugs A second helping of weight-loss
Description
10.1152/ajpendo.1996.271.3.E458
These data provide an explanation for CNS activation even though monoclonal antibodies have minimal brain penetrance, reaching concentrations of around 0.10.4% of the monoclonal antibody concentrations in the plasma 50,51
however, no significant differences in eGFR decline were identified in any of the treatment groups [44]
Riddle MC, Aronson R, Home P, Marre M, Niemoeller E, Miossec P, et al
A secondary comparison examined the effects of medications approved for AUD, such as disulfiram, acamprosate, and naltrexone
doi: 10.1055/s-2007-979981 60 SlavinBGOngJMKernPA
